Hematology Oncology Associates of the Treasure Coast
Port Saint Lucie, Florida, United States
Medical group in Port St. Lucie, Florida
1871 SE Tiffany Ave #100, Port St. Lucie, FL 34952
About Hematology Oncology Associates of the Treasure Coast
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hematology Oncology Associates of the Treasure Coast
During the past decade, Hematology Oncology Associates of the Treasure Coast conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 26 clinical trials were completed, i.e. on
average, 92.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 13 clinical trials were completed. i.e. 185.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3
2001-12-01
Completed
1,300
Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs
1999-03-01
2001-12-01
Completed
A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease
Completed
240
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
Completed
750
A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past
Completed
320
The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT
Completed
325
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
Completed
200
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hematology Oncology Associates of the Treasure Coast" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Bristol-Myers Squibb" with 4 trials
sponsored, "EMD Serono Research & Development Institute, Inc." with 4 trials sponsored, "Novartis Pharmaceuticals" with 4 trials sponsored and "Puma Biotechnology, Inc."
with 4 trials sponsored. Other sponsors include 48 different institutions and
companies that sponsored additional 45 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology Oncology Associates of the Treasure Coast"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Hematology Oncology Associates of the Treasure Coast
According to Clinical.Site data, the most researched conditions in "Hematology Oncology Associates of the Treasure Coast" are
"Breast Cancer" (12 trials), "Prostate Cancer" (7 trials), "Colorectal Cancer" (5 trials), "Non-Small Cell Lung Cancer" (5 trials) and "Non-small Cell Lung Cancer" (5 trials). Many other conditions were trialed in "Hematology Oncology Associates of the Treasure Coast" in a lesser frequency.
Clinical Trials Intervention Types at Hematology Oncology Associates of the Treasure Coast
Most popular intervention types in "Hematology Oncology Associates of the Treasure Coast" are "Drug" (72 trials), "Biological" (7 trials), "Other" (5 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Paclitaxel" (10 trials), "Carboplatin" (5 trials), "Docetaxel" (4 trials) and "Erlotinib" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Hematology Oncology Associates of the Treasure Coast
The vast majority of trials in "Hematology Oncology Associates of the Treasure Coast" are
55 trials for "All" genders, 12 trials for "Female" genders and 9 trials for "Male" genders.
Clinical Trials Status at Hematology Oncology Associates of the Treasure Coast
Currently, there are NaN active trials in "Hematology Oncology Associates of the Treasure Coast".
undefined are not yet recruiting,
8 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 45 completed trials in Hematology Oncology Associates of the Treasure Coast,
undefined suspended trials,
and 14 terminated clinical trials to date.
Out of the total trials that were conducted in Hematology Oncology Associates of the Treasure Coast, 17 "Phase 1"
clinical trials were conducted, 39 "Phase 2" clinical
trials and 24 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".